AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Highlights:
Berenberg Bank has lowered its price objective for Judges Scientific to £113.10, while maintaining a "buy" rating on the stock.
Analysts from Jefferies Financial Group and Shore Capital have also issued positive outlooks, with ratings of "buy" and "house stock" respectively.
Insider activity reveals notable sales of shares, including transactions by David Cicurel and Ralph Elman.
Judges Scientific (LSE:JDG) has experienced a recent shift in its analyst outlook, with Berenberg Bank reducing its price objective for the company’s stock from £124 to £113.10. Despite the lower price target, Berenberg has maintained a “buy” rating, suggesting the stock could see a potential upside of approximately 25.67% from its current price level. This update follows a broader trend, as other research firms have issued positive assessments of the company. For instance, Jefferies Financial Group initiated coverage with a "buy" rating and a target price of £122.30, while Shore Capital reaffirmed Judges Scientific as a “house stock,” signaling confidence in its performance.
In terms of stock performance, Judges Scientific opened at GBX 9,000, reflecting a slight decline from its recent high of £122.50. The company’s market capitalization currently stands at £597.60 million, with notable financial ratios, including a debt-to-equity ratio of 70.71 and a P/E ratio of 4,712.04, which suggests a higher-than-usual valuation. Over the past 200 days, the stock has maintained a simple moving average of £102.59, with a more recent 50-day average of GBX 9,576.11, indicating some fluctuation in price.
In addition to analyst updates, insider trading activity has also caught attention. Notably, David Cicurel and Ralph Elman, both insiders at Judges Scientific, have sold substantial amounts of company stock. Cicurel’s transaction involved 60,000 shares, while Elman sold 25,791 shares. Despite these sales, insiders continue to hold a significant portion of the company’s stock, representing 18.75% of the total shares outstanding.
Judges Scientific, a company known for designing and manufacturing scientific instruments, continues to receive strong ratings from analysts, even amidst fluctuating stock prices and insider activity. The company provides specialized equipment for various sectors, including education, food processing, and pharmaceuticals.
